The Innovations and Latest Treatments in Type 1 Diabetes was developed to enhance diabetes care with evidence-based guidelines from the ADA’s Standards of Care in Diabetes. In this six-part module, you’ll learn how to: 

• Implement the most widely recognized diabetes guidelines in clinical practice. 
• Identify timely and appropriate behavioral, lifestyle, and medication therapies for people with diabetes. 
• Address barriers to patient care as part of creating a personalized diabetes care plan. 
• Utilize strategies to improve the quality and quantity of constituent engagement, including the use of interactive diabetes technology. 

This self-paced course has the busy professional in mind with convenient online access to view content at your leisure. Earn up to six continuing education credits, one per module. Equip yourself with the latest professional tools to apply to your clinical practice.

Target Audience: This program is intended for physicians, physician assistants, nurse practitioners, nurses, dietitians, pharmacists, and other members of the primary care team who manage patients with type 1 diabetes. 

Module Topics:

• Module 1: Screening and Prevention; Emily K. Sims M.D. M.S; Pediatric Endocrinology
  
  
• Module 2:Genetics, Diagnosis, & Disease Progress; Evan A. Los, M.D.; Pediatric Endocrinology
  
  
• Module 3: Current Disease Management Strategies; Eric L. Johnson, M.D.; Family and Community Medicine
  
  
• Module 4: Monitoring and Preventing Complications; Michael K Heile, MD; Family Medicine
  
  
• Module 5: Barriers in Therapy Access and Utilization; Fran R Cogen, MD, CDCES; Pediatric Endocrinology
  
  
• Module 6: Emerging Therapies; Halis Akturk, MD; Endocrinology, Diabetes and Metabolism (Launching August 7th, 2023

Credits: The program includes 6 CE modules, the CE credit value of the program will be updated as modules are released. 

End Date: Participants will have from June 20, 2023 until December 31, 2024 to complete these modules.

This program is supported, in part, by unrestricted educational grants from Provention Bio and Vertex Pharmaceuticals